Navigation Links
Astellas Promotes Doug Geiger to Vice President, Head of New Therapeutic Areas in Marketing Strategy
Date:10/27/2015

NORTHBROOK, Ill., Oct. 27, 2015 /PRNewswire/ -- Astellas recently announced that Doug Geiger has been promoted to the position of vice president, head of New Therapeutic Areas in Marketing Strategy. Geiger will be responsible for delivering global strategic commercial leadership on key initiatives within Astellas' emerging therapeutic areas. He will report to Yukio Matsui, senior vice president and head of Marketing Strategy.

"Doug has been a pivotal strategic commercial leader since joining Astellas in 2008," said Matsui. "He will play an instrumental role as we establish a presence in new therapeutic focus areas such as pain, central nervous system, nephrology and inflammation."

Geiger brings 23 years of experience in the pharmaceutical industry. He joined Astellas in 2008 as director of New Product Planning in the U.S., and helped establish the oncology business unit. Since 2012, Geiger has served as senior director and head of the New Product Planning in the U.S., where he played a vital role in optimizing the commercial potential of Astellas' pipeline.

Prior to Astellas, Geiger held several commercial leadership positions at Abbott Laboratories and TAP Pharmaceuticals in marketing, commercial strategy and global commercial development. 

Geiger earned his Bachelor of Science in finance from the University of Illinois, holds a Master of Science in accounting from DePaul University Kellstadt Graduate School of Business and a Masters in Business Administration from Northwestern University Kellogg School of Management.  

About Astellas
Astellas is a pharmaceutical company dedicated to improving the health of people around the world through provision of innovative and reliable pharmaceuticals. For more information on Astellas, please visit our website at www.astellas.us, follow us on Twitter at www.twitter.com/AstellasUS or like our Facebook page at www.facebook.com/AstellasUS.

Photo - http://photos.prnewswire.com/prnh/20151027/281191
Logo - http://photos.prnewswire.com/prnh/20140416/84970

 


'/>"/>
SOURCE Astellas
Copyright©2015 PR Newswire.
All rights reserved


Related medicine technology :

1. Astellas and Chromocell Announce License and Collaboration Agreement to Develop and Commercialize New Therapies to Treat Neuropathic Pain
2. Astellas European Foundation gewährt Zuschüsse zur Untersuchung neuartiger molekularer Bildgebungstechniken für Patienten mit Prostatakrebs
3. Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections
4. Julie Monzo Joins Astellas Corporate Affairs
5. Astellas And Medivation Announce Enrollment Of The First Patients In Advanced Prostate Cancer Outcomes Registry
6. Astellas and The Chris Klug Foundation Announce Winners of the 2015 Bounce Back Award
7. Astellas Announces Preliminary Phase 1/2 Safety, Tolerability And Efficacy Data For ASP2215 In Patients With Relapsed Or Refractory Acute Myeloid Leukemia (AML)
8. Astellas Pharma EMEA Celebrates Its 10th Anniversary
9. Astellas honors 10 years of patient care and community involvement with Changing Tomorrow Day service activities
10. Astellas Announces New Data To Be Presented During Late Breaking Plenary Session At AUA Annual Meeting
11. Astellas Pharma And Potenza Therapeutics Partner To Build A Portfolio Of Immuno-Oncology Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2019)... ... July 10, 2019 , ... ... double-blind, placebo controlled clinical study from Ohio State University Wexner Medical Center ... containing urolithins, fulvic acid, and micro minerals. Natreon is committed to continued ...
(Date:7/10/2019)... ... July 10, 2019 , ... DidCBDWork.com is ... for the past 18 months, does CBD actually work? It seems like depending on ... oil. , DidCBDWork.com instead aims to get testimonials of real CBD users, who ...
(Date:7/9/2019)... FALLS CHURCH, Va. (PRWEB) , ... July 10, ... ... Firms, and Their Suppliers, **An interactive workshop presented by Cerulean Associates LLC and ... Bethesda, MD, https://www.fdanews.com/fdadataintegrity , Early Bird Savings: Register by Sept. 23 ...
Breaking Medicine Technology:
(Date:7/9/2019)... ... July 10, 2019 , ... Women's Excellence is excited to offer laser vaginal rejuvenation. Laser ... such as , painful sex , vaginal dryness ... , urinary urgency , vaginal pH imbalances , recurrent ...
(Date:7/9/2019)... ... July 09, 2019 , ... A2LA is pleased to announce the accreditation ... oils, and solids. GEL Laboratories is based in Charleston, South Carolina, and is the ... first laboratory in the field of environmental testing to expand their scope to include ...
(Date:7/9/2019)... Ohio and MT. PROSPECT, Ill. (PRWEB) , ... ... ... of patient flow, staff workflow, and asset tracking technology, today announced a validated ... call platform. , Midmark RTLS has been enhancing Rauland’s nurse call platform with ...
(Date:7/9/2019)... ... July 09, 2019 , ... ... it is expanding to the Canadian marketplace through a new strategic partnership with ... pig health and production management technology to Canada’s swine industry. The partnership is ...
(Date:7/9/2019)... ... July 08, 2019 , ... East Valley Implant and Periodontal Center (EVIP) ... the East Valley of Arizona. With two impressive practices in Mesa and Scottsdale, the ... Established in 2003, EVIP is led by founder and practicing periodontist Dr. Todd Jorgenson. ...
Breaking Medicine News(10 mins):